Abstract
Coronavirus disease 2019 (COVID-19) disrupts the intestinal micro-ecological balance, and patients often develop the intestinal disease. The gut is the largest immune organ in the human body; intestinal microbes can affect the immune function of the lungs through the gut-lung axis. It has been reported that tea polyphenols (TPs) have antiviral and prebiotic activity. In this review, we discussed TPs reduced lung-related diseases through gut-lung axis by inhibiting dysbiosis. In addition, we also highlighted the preventive and therapeutic effects of TPs on COVID-19 complications, further demonstrating the importance of research on TPs for the prevention and treatment of COVID-19 in humans. Based on this understanding, we recommend using TPs to regulate the gut microbiota to prevent or alleviate COVID-19 through the gut-lung axis.
Original language | English (US) |
---|---|
Article number | 899842 |
Journal | Frontiers in Nutrition |
Volume | 9 |
DOIs | |
State | Published - Apr 14 2022 |
Externally published | Yes |
All Science Journal Classification (ASJC) codes
- Food Science
- Endocrinology, Diabetes and Metabolism
- Nutrition and Dietetics
Keywords
- antiviral
- COVID-19
- gut microbiota
- gut-lung axis
- tea polyphenols